Details of the Drug

General Information of Drug (ID: DMXZKV7)

• Drug Name: Etripamil
• Synonyms: UNII-S82A18Y42P; S82A18Y42P; 1593673-23-4; Etripamil [USAN:INN]; Etripamil (USAN/INN); CHEMBL3707312; DB12605; Benzoic acid, 3-(2-(((4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl)methylamino)ethyl)- , methyl ester; D10932

Indication

Disease Entry	ICD 11	Status	REF
Cardiovascular disease	BA00-BE2Z	Phase 2	[1]
Paroxysmal supraventricular tachycardia	BC81.Z	Phase 2	[2]

• Chemical Identifiers:
  Formula: C27H36N2O4
  Canonical SMILES: CC(C)C(CCCN(C)CCC1=CC(=CC=C1)C(=O)OC)(C#N)C2=CC(=C(C=C2)OC)OC
  InChI: InChI=1S/C27H36N2O4/c1-20(2)27(19-28,23-11-12-24(31-4)25(18-23)32-5)14-8-15-29(3)16-13-21-9-7-10-22(17-21)26(30)33-6/h7,9-12,17-18,20H,8,13-16H2,1-6H3/t27-/m0/s1
  InChIKey: VAZNEHLGJGSQEL-MHZLTWQESA-N
• Cross-matching ID:
  PubChem CID: 91824132
  CAS Number: 1593673-23-4
  UNII: S82A18Y42P
  DrugBank ID: DB12605
  TTD ID: D04BKO
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT02296190) Efficacy and Safety of Intranasal MSP-2017 for the Conversion of PSVT to Sinus Rhythm (NODE-1). U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)